Education
About Us
Working with TipRanks
Follow Us
Pharmadrug Inc. (TSE:PHRX)
:PHRX
PHRX Stock Chart & Stats
Day’s Range― - ―
52-Week Range<C$0.01 - C$0.06
Previous CloseN/A
Volume5.00K
Average Volume (3M)105.15K
Market Cap
C$1.08M
Enterprise ValueC$2.36M
Total Cash (Recent Filing)C$128.12K
Total Debt (Recent Filing)C$1.40M
Price to Earnings (P/E)―
Beta1.18
Next Earnings
Aug 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding108,234,380
10 Day Avg. Volume131,523
30 Day Avg. Volume105,151
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)-0.73
Price to Sales (P/S)0.00
P/FCF Ratio-0.96
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Pharmadrug News
PremiumCompany Announcements
PharmaDrug Announces CEO Resignation and Leadership Transition
PremiumCompany Announcements
PharmaDrug Initiates Strategic Review to Enhance Shareholder Value
PremiumCompany Announcements
PharmaDrug Completes Strategic Debenture Issuance
PremiumCompany Announcements
PharmaDrug Debenture Units Issuance Announcement
PremiumCompany Announcements
PharmaDrug Advances PD-001 for Clinical TrialsPremiumCompany Announcements
PharmaDrug Begins Clinical Trial for Infectious Disease TreatmentPremiumCompany Announcements
PharmaDrug Advances PD-001 in Fight Against Viral DiseasesPremiumCompany Announcements
PharmaDrug’s Cepharanthine Shows Potential Against MonkeypoxPHRX FAQ
What was Pharmadrug Inc.’s price range in the past 12 months?
Pharmadrug Inc. lowest stock price was <C$0.01 and its highest was C$0.06 in the past 12 months.
What is Pharmadrug Inc.’s market cap?
Pharmadrug Inc.’s market cap is C$1.08M.
When is Pharmadrug Inc.’s upcoming earnings report date?
Pharmadrug Inc.’s upcoming earnings report date is Aug 27, 2025 which is in 29 days.
How were Pharmadrug Inc.’s earnings last quarter?
Currently, no data Available
Is Pharmadrug Inc. overvalued?
According to Wall Street analysts Pharmadrug Inc.’s price is currently Overvalued.
Does Pharmadrug Inc. pay dividends?
Pharmadrug Inc. does not currently pay dividends.
What is Pharmadrug Inc.’s EPS estimate?
Pharmadrug Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pharmadrug Inc. have?
Pharmadrug Inc. has 108,234,380 shares outstanding.
What happened to Pharmadrug Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Pharmadrug Inc.?
Currently, no hedge funds are holding shares in TSE:PHRX
Company Description
Pharmadrug Inc.
Pharmadrug (PHRX) is a publicly traded pharmaceutical company focused on the research, development, and commercialization of controlled substances and natural medicines. The company operates in the healthcare and biotechnology sectors, with a core emphasis on developing novel therapies and treatments that leverage both synthetic and plant-derived compounds. Pharmadrug aims to address unmet medical needs in various therapeutic areas, including mental health and pain management.